We further reveal that gastric cancer cells can activate fibroblasts to up-regulate HAPLN1 expression via the TGF-β1/Smad2/3 signaling activation, and that CAFs-derived HAPLN1 promotes tumour invasion through ECM remodeling. This evidence concerns the gene SMAD2 and gastric cancer.